Semaglutide's comes from the STEP 1 trial, about 15% mean loss at 68 weeks versus roughly 2% with placebo[1]
Thousand Oaks, Calif
Toradol (ketorolac) offers potent benefits as a nonsteroidal anti-inflammatory drug (NSAID)
The recruitment of p-NPM1 and -H2AX at DNA damage sites is an essential step in the DNA damage recognition and DNA repair process
Regular Exercise Why it matters: Physical activity burns calories, improves cardiovascular health, boosts mood, and enhances overall well-being
Hengruis Patent: A Catalyst in the GLP-1 Arena Hengruis patent, part of its $6B licensing deal with Hercules CM NewCo (Pharmaceutical Technology, 2024), covers innovative GLP-1/GIP dual agonists like HRS-9531 and oral small molecules like HRS-7535, both in Phase II/III trials for obesity and type 2 diabetes (Synapse PatSnap, 2024)